Biofrontera Inc. (BFRI)
USD 0.97
(-2.21%)
USD 0.97
(-2.21%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -24.89 Million | -16.19 Million | -26.71 Million | -12.36 Million | -37.67 Million |
| Net Income | -20.13 Million | -640 Thousand | -37.71 Million | -10.98 Million | -10.98 Million |
| Depreciation & Amortization | 1.06 Million | 1.17 Million | 540 Thousand | 562 Thousand | 667 Thousand |
| Deferred income taxes | -1.12 Million | - | 12.87 Million | - | - |
| Stock-based compensation | 1.04 Million | 1.85 Million | 129 Thousand | - | - |
| Change in working capital | -4.39 Million | 2.78 Million | -1.5 Million | -2.82 Million | -23.94 Million |
| Other non-cash items | -1.35 Million | -21.37 Million | -1.04 Million | 883 Thousand | -3.42 Million |
| Investing Cash Flow | 619 Thousand | -5.15 Million | -11 Thousand | - | 25.39 Million |
| Investments in PPE | -5000.00 | -38 Thousand | -11 Thousand | - | -538 Thousand |
| Acquisitions | - | - | - | - | 25.93 Million |
| Investment purchases | - | -5.11 Million | - | - | - |
| Sales/Maturities of investments | 624 Thousand | - | - | - | - |
| Other Investing Activities | 624 Thousand | -5.11 Million | - | - | - |
| Financing Cash Flow | 8.41 Million | 14.02 Million | 43.19 Million | 13.19 Million | 16.4 Million |
| Debt repayment | -3.9 Million | - | - | -8.79 Million | -13.5 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 4.5 Million | 14.02 Million | 29.93 Million | - | - |
| Other Financing Activities | 7.8 Million | 14.02 Million | 13.25 Million | 21.98 Million | 29.9 Million |
| Accounts receivables | 4.93 Million | -70 Thousand | -612 Thousand | 1.16 Million | -757 Thousand |
| Accounts payables | 6.41 Million | 912 Thousand | -773 Thousand | -6.65 Million | 1.43 Million |
| Inventory | -3.75 Million | -2.81 Million | 2.59 Million | 2.97 Million | -3.53 Million |
| Other working capital | -11.99 Million | 4.75 Million | -2.71 Million | -321 Thousand | -21.08 Million |
| Cash at beginning of period | 17.2 Million | 24.74 Million | 8.27 Million | 7.45 Million | 3.33 Million |
| Cash at end of period | 1.34 Million | 17.4 Million | 24.74 Million | 8.27 Million | 7.45 Million |
| Capital Expenditure | -5000.00 | -38 Thousand | -11 Thousand | - | -538 Thousand |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -15.86 Million | -7.33 Million | 16.46 Million | 825 Thousand | 4.11 Million |
| Free Cash Flow | -24.9 Million | -16.23 Million | -26.72 Million | -12.36 Million | -38.21 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -257 Thousand | -10.43 Million | 3.52 Million | -20.13 Million | -6.34 Million | -9.83 Million |
| Depreciation & Amortization | 309 Thousand | 307 Thousand | 295 Thousand | 1.06 Million | 251 Thousand | 252 Thousand |
| Deferred income taxes | - | - | 6.09 Million | -1.12 Million | 1.7 Million | 1.15 Million |
| Stock-based compensation | 204 Thousand | 228 Thousand | 228 Thousand | 1.04 Million | 207 Thousand | 259 Thousand |
| Change in working capital | 342 Thousand | 2.61 Million | -5.24 Million | -4.39 Million | 1.86 Million | -2.36 Million |
| Other non-cash items | -5.54 Million | 1.63 Million | -13.76 Million | -1.35 Million | 306 Thousand | 201 Thousand |
| Investing Cash Flow | -2000.00 | - | 73 Thousand | 619 Thousand | 382 Thousand | 178 Thousand |
| Investments in PPE | -2000.00 | -57 Thousand | 9000.00 | -5000.00 | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | 57 Thousand | 64 Thousand | 624 Thousand | 382 Thousand | 178 Thousand |
| Other Investing Activities | -50 Thousand | 57 Thousand | 64 Thousand | 624 Thousand | 382 Thousand | 178 Thousand |
| Financing Cash Flow | 5.28 Million | 5.79 Million | 6.71 Million | 8.41 Million | 591 Thousand | 1.1 Million |
| Debt repayment | -1.79 Million | -1.86 Million | -2.2 Million | -3.9 Million | -7.25 Million | -1.1 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 7.43 Million | 7.66 Million | 4.5 Million | 4.5 Million | - | - |
| Other Financing Activities | -357 Thousand | -357 Thousand | 4.41 Million | 7.8 Million | 7.84 Million | 1.1 Million |
| Accounts receivables | 173 Thousand | 1.41 Million | 1.48 Million | 4.93 Million | -1.69 Million | 1.87 Million |
| Accounts payables | -2.08 Million | -2.25 Million | 278 Thousand | 6.41 Million | 2.75 Million | 4.17 Million |
| Inventory | 2.95 Million | 4 Million | 5.15 Million | -3.75 Million | -1.28 Million | -8.11 Million |
| Other working capital | -709 Thousand | -546 Thousand | -12.16 Million | -11.99 Million | 2.08 Million | -296.99 Thousand |
| Cash at beginning of period | 3.81 Million | 1.34 Million | 3.42 Million | 17.2 Million | 4.65 Million | 13.7 Million |
| Cash at end of period | 4.37 Million | 3.81 Million | 1.34 Million | 1.34 Million | 3.62 Million | 4.65 Million |
| Capital Expenditure | -2000.00 | -57 Thousand | 9000.00 | -5000.00 | - | - |
| Effect of forex changes on cash | - | - | 5.95 Million | - | -4.85 Million | - |
| Net cash flow / Change in cash | 562 Thousand | 2.47 Million | -2.07 Million | -15.86 Million | -1.03 Million | -9.05 Million |
| Free Cash Flow | -4.72 Million | -3.38 Million | -8.85 Million | -24.9 Million | -2 Million | -10.33 Million |
0I47
7707
8518
GGNPF
002578
CSCMY